UK small-cap RNS · 17 Mar 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Sort: Newest · Largest companies
-
11:52
-
10:25
-
07:00
Launch of Share Buyback ProgrammeLaunches a buyback of up to £5.0m, with shares cancelled, funded from a strong balance sheet. It follows capital returned in 2025 and sits alongside continued investment in strategy.Moved: £5.0m share buyback: Started 17 March 2026 → Programme formally launched; purchases begin 17 March 2026
-
07:00
Awarding of Orphan Drug Designation by the FDAFDA Orphan Drug Designation for irinotecan in malignant glioma, wider than the glioblastoma requested, brings a potential seven years of US exclusivity, trial tax credits and fee exemption for the lead programme.Moved: new: Irinotecan-ChemoSeed glioblastoma Phase 2 – Registration-grade Phase 2 under way; ODD granted
-
07:00
Boku, Inc BOKU £382m2025 Full Year Results ResultsAudited FY2025 confirms the January trading update: revenue of $128.8m and adjusted EBITDA of $41.3m, both slightly above the c.$128.5m and c.$41m flagged. Growth is led by Digital Wallets & A2A and Bundling, margin is 32.1%, and medium-term guidance is unchanged.Moved: FY2025 revenue growth at least in line with underlying H1 rate of 27%.: on_track → delivered – FY2025 revenue growth of 30% (29% CER) exceeded the underlying H1 rate of 27%. · Ramp up direct sales activity to add new merchants in 2026.: pending → on_track – Negotiations for new merchant partnerships have begun, and the company expects them to go live in 2026. · Share buyback programme: Ongoing; 5.8m shares repurchased in 2025 → 5.8m shares bought in 2025; 4m more in Jan-Feb 2026
-
07:00
STV Group STVG £46mSTV Group Full Year Results to 31 December 2025 Resultso Total Advertising Revenue (TAR) of £89.3m, down 10%, driven by national linearMoved: Cost savings programme: On track → £4.1m of £8m delivered; on track · STV Radio launch: Launched January 2026, early positive response → Launched Jan-26; attracting advertisers · Full year results: Results date set → FY25 results published in line (closed)
-
07:00
Audited Full Year Results 2025 ResultsRevenue was flat and profit fell: adjusted EBITDA down 5.4% and adjusted EPS down 16.6%, because of the signalled Facilisgroup sales investment. Brand Addition margins improved and cash conversion rose to 91%.Moved: new: £5.0m share buyback – Started 17 March 2026 · new: Facilisgroup Partner growth investment – 30 new Partners won in FY 25
-
07:00
Strategic Minerals SML £135mRedmoor - Infill Drilling Contract SignedDrilling contract with Priority Drilling UK for the infill campaign is signed and a rig is on site. It is funded by the January £4m placing, moving Redmoor towards a PFS.Moved: Redmoor drilling and MRE update: Pad 3 final hole CRD041 reported; CRD039 delayed → Infill drilling contracted, rig on site
-
07:00
Wickes Group WIX £506mFinal Results ResultsFY25 adjusted PBT rose 14.4% to £49.9m, inside the £46.8m-£50.7m consensus range guided in January, on volume-led growth and operating leverage. The company calls it ahead of expectations.Moved: Design & Installation recovery: Ordered sales up five quarters; delivered sales up three → Five quarters ordered growth; H2 delivered LFL +6.1% · Store openings and SaaS investment: Five new stores in 2025; 83% of estate in new format → 5 new stores, 11 refits; 300-store ambition
-
07:00
BSF Enterprise BSFA £1.9mLGL Tanning MilestonesLGL has successfully tanned scaffold-free, cultivated skin in A4-sized sheets, marking a critical step toward the large-scale commercialisation of sustainable luxury and ultra-luxury materials.Project milestones +24.6% on the dayMoved: Lab-grown leather commercial launch: First A4 tanned skin made; still pre-revenue → A4 sheets tanned; samples to fashion house